[BGLC] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
14-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 68.57%
YoY- 75.28%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,630 2,554 2,575 3,576 23 24 92 74.77%
PBT -1,345 -2,532 -67 370 -60 -50 -89 57.17%
Tax 0 76 10 75 0 -28 0 -
NP -1,345 -2,608 -77 295 234 -22 -89 57.17%
Tax Rate - - - -20.29% - - - -
Total Cost 3,976 5,162 2,652 3,281 -211 46 181 67.27%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -51.15 -102.13 -3.01 8.26 998.93 -91.13 -97.09 -10.12%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.07 -0.16 -0.01 0.02 0.03 -0.00 -0.02 23.19%
EPS Diluted -0.07 -0.16 -0.01 0.02 0.03 -0.00 -0.02 23.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.